Diagnosis of Crohn's disease (CD) is often challenging and ... 1 Chair of Gastroenterology, Department of Clinical and Experimental Pathology, University of Udine School of Medicine, 33100 Udine ...

Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...

Steven Craig Collins II (who goes by Craig) was diagnosed with Crohn's disease at 14 years old. He experienced years of poor health, surgeries, and low self-esteem—but he's battled through ...

Crohn’s disease is more than just a digestive disorder. It is a chronic autoimmune condition that triggers inflammation anywhere along the gastrointestinal tract, from the mouth to the anus.

The number of cases of Crohn’s disease and IBD are rising dramatically ... the Translational Research in Intestinal Physiology and Pathology (TRIPP) study at the University of Cambridge.

A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume ...

“Before a trip, I worry that my Crohn’s disease might flare up, even if I’m currently in remission,” she says. “I get anxious about what restroom facilities I'll have near me, the ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults. Omvoh targets interleukin ...